TWiV 770: COVID-19 clinical update #67 with Dr. Daniel Griffin

In COVID-19 clinical update #67, Daniel Griffin reviews antibodies to the virus early in the US, serology testing of blood donations, MIS-C in children under 21, myocarditis in competitive athletes, ER visits for suspected suicide attempts, delta variant in Scotland, Novavax vaccine phase 3 results, vaccine coverage in pregnant women, early monoclonal administration reduces hospitalization and mortality, casirivimab and imdevimab recovery trial results, and CDC guidance on postacute sequelae. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Antiviral antibodies early in US outbreak (CID) Serologic testing of US blood donations (CID) The virus, what went wrong (PBS) MIS-C in children (JAMA) Myocarditis in competitive athletes (JAMA) ER visits for suspected suicide (MMWR) Delta variant in Scotland (Lancet) Novavax phase 3 results (Novavax) Vaccine coverage in pregnant women (MMWR) Early mAb reduces hospitalization and mortality (CID) Regen-Cov trial results (Regeneron) Guidance on postacute sequelae (CDC) Letters read on TWiV 770 Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]